BONE, METASTATIC CANCER

Clinical trials for BONE, METASTATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new BONE, METASTATIC CANCER trials appear

Sign up with your email to follow new studies for BONE, METASTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for kidney cancer patients with bone tumors

Disease control Not yet recruiting

This study tests a drug called zanzalintinib, combined with a bone-strengthening agent, in 20 people with advanced clear cell kidney cancer that has spread to the bones. Participants must have already tried 1-3 prior treatments, including immunotherapy. The goal is to see if the …

Matched conditions: BONE, METASTATIC CANCER

Phase: PHASE2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control

Last updated May 10, 2026 13:04 UTC

BONE, METASTATIC CANCER

Get alerted when new BONE, METASTATIC CANCER trials appear

New hope for kidney cancer patients with bone tumors